Introduction {#s1}
============

Small molecules commonly drive productive and destructive relationships between species. The breadth of these molecular messages is vividly illustrated by examples ranging from bacterial control of fungal pathogenesis to programming of multi-cellular development ([@bib2]; [@bib16]; [@bib25]; [@bib26]). Small molecule interactions between mammals and their associated gut microbiota may have important consequences for human health ([@bib13]; [@bib38]). Cross-kingdom interactions also have commercial relevance -- for example those that occur between yeast and bacteria in the fermentation of alcoholic beverages ([@bib5]; [@bib6]; [@bib7]). Pasteur and others since have noted that lactic acid bacteria are a common contaminant in incomplete fermentations ([@bib7]; [@bib43]). Indeed, brewers and vintners have long appreciated that some bacteria have the power to both reduce the ethanol content and spoil the taste profile of fermented beverages.

The budding yeast *S. cerevisiae* is a metabolic specialist: it strongly favors glucose as a carbon source even when other carbohydrates are present ([@bib31]). This is achieved through stringent regulation of enzymes involved in glycolysis and respiration at both the transcriptional and post-transcriptional levels ([@bib31]; [@bib56]). Such glucose-associated repression of metabolism is a defining feature of *S. cerevisiae*, and many other microorganisms ([@bib23]). A similar preference for glycolytic metabolism, even in the presence of oxygen, is a defining feature of cancer cells, known as the 'Warburg effect' ([@bib28]; [@bib37]; [@bib50]; [@bib51]).

When yeast cultures switch from metabolizing glucose to utilizing a respirative carbon source such as glycerol, they experience a pronounced lag phase known as the diauxic shift. This pause in growth occurs as a new transcriptional program is engaged to favor respiration ([@bib21]; [@bib56]). The robust nature of this glucose-associated repression can be readily observed by using glucose mimetics. Even in trace quantities, these molecules provide a stable glucose signal, but cannot be metabolized. For example, just 0.05% of the mimetic glucosamine prevents yeast cells from utilizing non-fermentable carbon sources present at 40-fold higher concentrations ([@bib3]; [@bib9]; [@bib34]).

We recently reported that yeast strains have the ability to overcome such glucose-associated repression of metabolism at frequencies that depend upon the ecological niche from which they were isolated ([@bib29], [@bib30]). This allows them to switch from being metabolic specialists to metabolic generalists, gaining the ability to metabolize a wide variety of carbon sources in the presence of glucose. This heritable change in metabolic program is not accompanied by a change in the yeast genotype. Rather, the trait is cytoplasmically transduced from mother cells to their daughters through the inheritance of an altered protein conformation -- a prion known as \[*GAR*^+^\] (named for its ability to reverse [g]{.ul}lucose [a]{.ul}ssociated [r]{.ul}epression) ([@bib9]). Although the molecular details of \[*GAR*^+^\] are incompletely understood, several operational tests to identify and modify it are known. \[*GAR*^+^\]'s nomenclature derives from defining characteristics of prion biology: dominance in genetic crosses (denoted by capital letters) and transmission to all progeny of meiosis (denoted by brackets). The ability to acquire \[*GAR*^+^\] has been widely conserved among wild *S. cerevisiae* strains and is also present in fungal species separated by at least two hundred million years of evolution ([@bib30]).

Under monoculture conditions in the laboratory, acquisition of \[*GAR*^+^\] occurs much more frequently than spontaneous mutations that reverse glucose repression ([@bib9]). In nature, the precise rates of \[*GAR*^+^\] appearance correlate with environmental niche from which yeast are derived, suggestive of a bet-hedging mechanism for adaptation in environments with fluctuating carbon stores ([@bib22]; [@bib30]; [@bib35]). Perhaps most remarkably, \[*GAR*^+^\] can be induced by cross-kingdom communication with many bacterial species, and this interaction has been conserved over long evolutionary timescales ([@bib29], [@bib30]). Notably, this relationship substantiates a model in which \[*GAR*^+^\]'s benefit as a reversible bet-hedging element would alone be sufficient to motivate its evolutionary retention ([@bib30]).

Induction of \[*GAR*^+^\] by bacteria occurs with an extremely high efficiency -- orders of magnitude greater than the spontaneous acquisition rate -- and the consequences are mutually beneficial. \[*GAR*^+^\] yeast cells gain the ability to metabolize a wider range of carbohydrates, improved uptake of limiting nutrients, and increased chronological lifespan ([@bib29]). \[*GAR*^+^\] yeast cells also produce less ethanol, which itself has anti-bacterial properties. This generates a more hospitable environment for the inducing bacteria and allows them to flourish in fermentations where they would otherwise have perished ([@bib29]); bacterial species that strongly induce \[*GAR*^+^\] are common contaminants in failed wine fermentations ([@bib5]; [@bib7]; [@bib29]). When yeast and inducing bacteria are co-cultured on solid medium, induction of \[*GAR*^+^\] occurs along a spatial gradient emanating from the bacteria. Conditioned medium generated from cultures of these bacteria also induces the prion ([@bib29]). These results and others have led us to propose that inducing bacteria produce a diffusible signal that promotes \[*GAR*^+^\] in yeast.

Here we report that the common bacterial metabolite lactic acid can serve as this inducing signal. Different concentrations of lactic acid elicit distinct and heritable \[*GAR*^+^\]-like phenotypes that have the properties of 'strong' and 'weak' variants of the prion. Lactic acid also has the capacity to induce \[*GAR*^+^\]-like epigenetic states in evolutionarily distant organisms in which glucose repression has evolved independently. Our results suggest that \[*GAR*^+^\] induction may provide a molecular explanation for Pasteur's observations, and indicate that links between lactate and diversification of metabolic strategies have been repeatedly employed to modulate the collective behavior of eukaryotic cells. More importantly, we for the first time uncover a bacterially secreted molecule that induces a prion. We do so using a straightforward approach with few technical prerequisites, which we propose could be used for discovering other natural molecules that potentiate epigenetic transformations.

Results {#s2}
=======

Lactic acid induces robust and heritable reversal of glucose repression {#s2-1}
-----------------------------------------------------------------------

Diverse bacteria have the capacity to induce \[*GAR*^+^\] in neighboring yeast cells through a cross-kingdom chemical communication. To characterize the diffusible element that was responsible for eliciting this change in yeast metabolism, we employed activity guided fractionation. We first grew large-volume cultures of the inducing bacteria *S. gallinarum* and *L. innocua* to saturation in rich media containing glycerol as a principle carbon source (YP-glycerol). After removing the bacteria from the media by filtration to create a sterile conditioned medium, we assessed its capacity to induce growth on media containing glycerol (2%) and glucosamine (0.05%), hereafter abbreviated as GLY + GlcN. GlcN provides a stable, non-metabolizable glucose signal ([@bib3]; [@bib34]). Serial dilutions of naïve \[*gar*^−^\] yeast did not grow on GLY + GlcN alone over a five day period, but pre-treatment with the conditioned medium caused the yeast cells to grow robustly.

We then purified the extracts from each inducing bacterium using reversed-phase high performance liquid chromatography (HPLC) on a C18 column. We collected fractions and monitored their ability to induce yeast cells to grow in GLY + GlcN. Pre-treatment with this purified extract afforded growth to a similar degree as *S. gallinarum* itself ([Figure 1A](#fig1){ref-type="fig"}). After these two rounds of purification, the inducing activity eluted in a single fraction as a homogenous peak. We combined active fractions from multiple injections and analyzed this peak by NMR and mass spectrometry. Both analyses revealed that the active fraction contained high concentrations of lactic acid ([Figure 1B](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).10.7554/eLife.17978.003Figure 1.Identification of the small molecule that induces \[*GAR*^+^\] in a concentration dependent manner.(**A**) *S. gallinarum* spotted next to yeast on GLY + GlcN (YP with 2% glycerol and 0.05% glucosamine) induced growth of naïve *S. cerevisiae* in a spatially dependent manner. An extract prepared from a *S. gallinarum* conditioned medium induced \[*GAR*^+^\] with similar strength. Each panel shows two biological replicates of yeast colonies spotted in five-fold serial dilutions from saturated cultures. (Bacterial spots are undiluted.) (**B**) Multiple-reaction monitoring-mass spectrometry (*m/z* 89.0200, 43.1000) traces of pure lactic acid (top), the purified active fraction from *S. gallinarum* conditioned medium (middle) and a co-injection of active fraction spiked with pure lactic acid (bottom). Results indicate that lactic acid is present in the active fraction (see Materials and methods). Note that y-axis scale differs between the top two traces due to the difference of lactic acid concentration in the pure standard, but they are normalized here for ease of viewing. (**C**) Plating assay (see Materials and methods) showing that both L- and D- isomers of lactic acid strongly induce \[*GAR*^+^\] in a concentration dependent manner. Plotted are the fraction of total colony forming units (CFUs) that grew on GLY + GlcN (mean with standard deviation from three biological replicates). Ten-fold dilutions were used for plates lacking lactic acid; 1000-fold and 10,000-fold dilutions were used for plates containing 0.025% LA and 0.625% LA, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.003](10.7554/eLife.17978.003)10.7554/eLife.17978.004Figure 1---figure supplement 1.Flow chart depicting the activity guided fractionation strategy used to identify the small molecule that induces \[*GAR*^+^\].**DOI:** [http://dx.doi.org/10.7554/eLife.17978.004](10.7554/eLife.17978.004)10.7554/eLife.17978.005Figure 1---figure supplement 2.Growth curves---of cells that start as \[*gar*^−^\] at the outset of the experiment---in synthetic complete media (Sigma-Aldrich) containing glucosamine, with or without 0.1% L-lactic acid added.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.005](10.7554/eLife.17978.005)10.7554/eLife.17978.006Figure 1---figure supplement 3.Growth rates of \[*GAR*^+^\] and \[*gar^−^*\] cells do not differ in the presence of lactic acid.Four biological replicates of \[*GAR*^+^\] or \[*gar^−^*\] cells were grown in GLY or GLY + 0.35% D-lactic acid liquid media, with OD~600~ measurements taken every six minutes over four days using an automated Eon microplate reader (BioTek Instruments, Winooski, VT). \[*GAR*^+^\] cells neither grew faster than \[*gar*^−^\] cells in glycerol alone nor when lactic acid was added. (Note that \[*GAR*^+^\] cells did have a slightly longer lag time, *i.e.* slightly more time passed before they entered exponential phase, even though their growth rate during exponential phase was equivalent to that of \[*gar^−^*\] cells.) Solid lines mark mean values, dashed lines standard deviation.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.006](10.7554/eLife.17978.006)

Lactic acid, a small organic molecule, exists in two distinct forms: L-(+)-lactic acid (L-LA) and its mirror image D-(--)-lactic acid (D-LA). Both occur naturally. Some bacteria, including the class known as lactic acid bacteria (LAB), have the ability to produce one or both forms from carbohydrates ([@bib17]; [@bib46]). Eukaryotes typically can metabolize both isomers, sometimes to varying degrees ([@bib1]; [@bib42]). Malolactic fermentation by LAB in winemaking can typically yield up to 2.5 g/L of lactic acid, or 0.25% ([@bib7]); in other fermented foods, concentrations can exceed 10 g/L, or \>1% ([@bib20]; [@bib44]). Moreover, many bacterial species that we previously found to strongly induce \[*GAR*^+^\] are known LAB ([@bib29]).

To establish whether lactic acid was sufficient to induce heritable reversal of glucose repression in *S. cerevisiae*, we tested the ability of yeast to grow on GLY + GlcN agar plates supplemented with concentrations of L- or D-lactic acid at 0.025 or 0.625%. We saw robust reversal of glucose repression in this range from both stereoisomers, in a concentration dependent manner ([Figure 1C](#fig1){ref-type="fig"}). D-lactic acid induced cells to acquire the phenotype slightly more rapidly (data not shown). Addition of 0.05% lactic acid did not increase growth on YP alone, eliminating the possibility that the yeast were simply metabolizing the lactic acid (data not shown). Induction was also robust in synthetic complete medium, further establishing that it was due to the added lactic acid, rather than unknown components of the medium (e.g. yeast extract, peptone, or an unknown metabolite therein; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Finally, we addressed the possibility that the presence of lactic acid could select for pre-existing \[*GAR*^+^\] cells, as opposed to true induction of \[*gar*^−^\] cells into the \[*GAR*^+^\] state. We examined the growth rates of isogenic \[*GAR*^+^\] cells and \[*gar^−^*\] cells in liquid YP-glycerol (GLY) alone or in YP-glycerol supplemented with 0.35% lactic acid. We did not observe any significant prion-dependent differences in growth ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), supporting an induction mechanism rather than selection of a pre-existing population.

Reversal of glucose-associated repression is due to \[*GAR*^+^\] {#s2-2}
----------------------------------------------------------------

Glucose repression can be commonly circumvented in *S. cerevisiae* by induction of the \[*GAR*^+^\] prion, but it can less frequently arise from genetic mutations ([@bib3]; [@bib34]) and, in principle, from other heritable epigenetic modifications ([@bib29], [@bib30]). We thus tested whether the reversal of glucose repression that we observed in response to lactic acid was due to \[*GAR*^+^\]. To do so we examined hallmarks of prion-based inheritance: dominance in genetic crosses and the ability to be heritably reduced or eliminated by perturbations in chaperone activity ([@bib47]; [@bib52]). We first mated yeast cells that had been induced with 0.1% lactic acid to naïve isogenic mating partners and selected for diploids. All diploids we tested grew on GLY + GlcN medium, and moreover exhibited the same unusual pattern of semi-dominance ([Figure 2A](#fig2){ref-type="fig"}) -- in which the diploid cells exhibit a strength of reversal of glucose repression that is intermediate between the two haploid parents -- that is highly characteristic of both spontaneous and bacterially-induced \[*GAR*^+^\] ([@bib9]; [@bib29]). We next sporulated diploid cells induced with lactic acid, dissected multiple tetrads, and examined the ability of the resulting spores to grow on GLY + GlcN. Nearly all spores we tested (29 of 31) exhibited the \[*GAR*^+^\] phenotype, in agreement with the non-Mendelian, dominant inheritance previously noted for both spontaneous and bacterially induced \[*GAR*^+^\] cells ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).10.7554/eLife.17978.007Figure 2.Lactic acid induced \[*GAR*^+^\] has the same prion-like features as spontaneous \[*GAR*^+^\].(**A**) Dominance in crosses between \[*GAR*^+^\] strains and \[*gar*^−^\] strains is seen in colonies isolated from a GLY + GlcN plate (spontaneous \[*GAR*^+^\]), as well as those induced with 0.1% D-lactic acid (LA-induced \[*GAR*^+^\]). Five-fold serial dilutions are shown for three biological replicates; orange coloring indicates strains exhibiting the \[*GAR*^+^\] phenotype. (**B**) Lactic acid-induced cells can be cured of the \[*GAR*^+^\] phenotype with transient expression of a dominant negative Hsp70 variant (Ssa1-K69M or Hsp70^DN^). Single colonies were propagated alone or with a plasmid expressing Hsp70^DN^ for \~125 generations, bottlenecked each \~25 generations. After verifying plasmid loss, colonies were again tested for their capacity to grow on GLY + GlcN medium. Each image shows five-fold serial dilutions for three biological replicates. (**C**) A strain with diminished expression of *PMA1, pma1-DAmP*, has reduced spontaneous \[*GAR*^+^\] acquisition and is not induced by lactic acid. Lactic acid-induction frequencies differ from those in [Figure 1C](#fig1){ref-type="fig"} due to strain background BY4741, which has a lower frequency of \[*GAR*^+^\] acquisition ([@bib9]). Plotted as in [Figure 1C](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.007](10.7554/eLife.17978.007)10.7554/eLife.17978.008Figure 2---figure supplement 1.Both spontaneous and lactic acid-induced \[*GAR*^+^\] diploids transmit the phenotype through meiosis to nearly all spores, demonstrating non-Mendelian inheritance.Representative spores from control (4), spontaneous \[*GAR*^+^\] (8), and lactic acid-induced \[*GAR*^+^\] diploids (16) are shown. Five-fold serial dilutions are shown for each spore.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.008](10.7554/eLife.17978.008)10.7554/eLife.17978.009Figure 2---figure supplement 2.Both spontaneous \[*GAR*^+^\] cells and lactic acid-induced \[*GAR*^+^\] *S. cerevisiae* cells exhibited sensitivity to the Hsp70 inhibitor myricetin (50 μM) on GLY + GlcN medium.Each image shows five-fold serial dilutions for two representative biological replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.009](10.7554/eLife.17978.009)

\[*GAR*^+^\] is unusual among known prions in that it is not influenced by perturbation of the Hsp104 disaggregase ([@bib9]; [@bib29]). Instead it is sensitive to perturbation of Hsp70 function ([@bib9]; [@bib29], [@bib30]). We assembled multiple colonies that had been induced with lactic acid to grow on GLY + GlcN plates. We then transformed them with a plasmid that constitutively expressed a dominant negative Hsp70 variant (Ssa1-K69M, or Hsp70^DN^). We passaged these cells five times on media that selected for the plasmid. We then passaged them three times on non-selective plates (and confirmed plasmid loss) before retesting them on GLY + GlcN plates. This regimen cured multiple independent clones of their induced \[*GAR*^+^\] phenotype, indicating that the lactic acid induced colonies have the same Hsp70-dependency as spontaneous and bacterially induced \[*GAR*^+^\] cells ([Figure 2B](#fig2){ref-type="fig"}). We also grew induced cells on plates containing an Hsp70 inhibitor, myricetin ([@bib11]; [@bib33]), at concentrations that did not affect growth on GLY medium. This regimen, which has been shown to inhibit the growth of both spontaneous and bacterially induced \[*GAR*^+^\] on GLY + GlcN ([@bib30]), also reduced the ability of these colonies to circumvent glucose repression that had been induced by lactic acid ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

We next tested whether our lactic acid induced isolates exhibited genetic characteristics related to proteins originally linked to spontaneous \[*GAR*^+^\]. *PMA1* encodes the essential major plasma membrane proton pump in yeast; in \[*GAR*^+^\] cells Pma1 adopts an altered conformation and associates more strongly with another protein, Std1 ([@bib9]). Because *PMA1* is essential, we employed *pma1-DAmP*, a degron allele that reduces the amount of protein expressed ([@bib8]). Cells harboring this allele had a low frequency of spontaneous prion acquisition, and could not be induced to acquire \[*GAR*^+^\] by exposure to lactic acid ([Figure 2C](#fig2){ref-type="fig"}). Thus, the heritable bypass of glucose repression induced by lactic acid has the same prion-like patterns of inheritance and depends upon the same proteins as spontaneous and bacterially induced \[*GAR*^+^\]. Although this lactic acid-induced epigenetic state could in principle differ from the spontaneous prion in other unknown ways, for simplicity we hereafter refer to it as \[*GAR*^+^\].

Influence of yeast lactic acid metabolism on \[*GAR^+^*\] induction {#s2-3}
-------------------------------------------------------------------

Lactic acid can be imported into yeast via saturable ("active"\') and unsaturable (\'passive\') mechanisms ([@bib10]; [@bib40]; [@bib41]). Both depend upon the transcription factor *SOK2*, and the active mechanism is ultimately mediated by the monocarboxylate transporter *JEN1*. Jen1 is required for yeast to grow on lactic acid as a sole carbon source, but is down-regulated during glucose repression ([@bib10]; [@bib40]), and its transcript was not abundant in \[*GAR*^+^\] cells compared to control cells ([@bib9]; [@bib29]). Deletion of *JEN1* greatly reduces growth on glycerol compared to wild-type cells, precluding its emergence in the previous screens for genes affecting \[*GAR*^+^\] ([@bib9]; [@bib29]). We therefore tested if lactic acid could induce *jen1*∆ cells to acquire \[*GAR*^+^\]. Deletion of *JEN1* did not influence \[*GAR*^+^\] induction by lactic acid at either low or high concentrations ([Figure 3A,B](#fig3){ref-type="fig"}), indicating that active transport is not required. We also tested whether enzymes reported to be involved in lactic acid metabolism in the *Saccharomyces* Genome Database ([@bib12]) could influence the ability of this molecule to induce \[*GAR*^+^\]. Individual deletion of these various lactic acid dehydrogenases and transhydrogenases (*DLD1, DLD2, DLD3*, and *CYB2*) also had no significant effect on \[*GAR*^+^\] induction by lactic acid ([Figure 3A,B](#fig3){ref-type="fig"}). Thus, the cellular mechanisms engaged by lactic acid to induce \[*GAR*^+^\] do not require its active import or its metabolism.10.7554/eLife.17978.010Figure 3.Analysis of induction frequencies in deletion mutants of genes with roles in lactic acid metabolism.(**A**) Plating assay (see Materials and methods) measuring induction of \[*GAR*^+^\] at a low (left) or high concentration (right) of L-lactic acid. Strains are in the W303 background, and cell dilutions match those in [Figure 1C](#fig1){ref-type="fig"}. We note that annotations of *DLD2* and *DLD3* as D-lactate dehydrogenases have recently been challenged by data suggesting they are instead transhydrogenases ([@bib4]). Only *DLD1* is required for yeast to grow on D-lactic acid as a sole carbon source. Plotted the same as in [Figure 1C](#fig1){ref-type="fig"}. **B**.) Plating assay measuring induction of \[*GAR*^+^\] by D-lactic acid. Otherwise as in (**A**).**DOI:** [http://dx.doi.org/10.7554/eLife.17978.010](10.7554/eLife.17978.010)

*SOK2* previously emerged as a hit in the screen for yeast mutants that were impaired in their ability to acquire \[*GAR*^+^\] upon induction by the bacterium *Staphylococcus hominis* ([@bib29]). We replicated this result using *S. gallinarum* in a co-plating assay on GLY + GlcN ([Figure 4A](#fig4){ref-type="fig"}). We then tested whether loss of *SOK2* impaired the capacity of lactic acid alone to induce \[*GAR*^+^\] in yeast cells. It did: yeast cells in which *SOK2* was deleted were not induced by lactic acid ([Figure 4B](#fig4){ref-type="fig"}). Thus, the previously described passive import of lactic acid ([@bib41]) is likely the dominant means through which this inducing signal is transmitted from bacteria to neighboring fungi.10.7554/eLife.17978.011Figure 4.Full induction by *S. gallinarum* or lactic acid requires the yeast transcription factor *SOK2*.(**A**) *S. gallinarum* spotted next to either wild type or *sok2*∆ yeast cells on GLY + GlcN, or control medium GLY. (**B**) Plating assay (see Materials and methods) comparing spontaneous and lactic acid-induced \[*GAR*^+^\] frequency in wild type and *sok2*∆ cells. Lactic acid-induction frequencies differ from those in [Figure 1C](#fig1){ref-type="fig"} due to strain background BY4741, which has a lower frequency of \[*GAR*^+^\] acquisition ([@bib9]). Plotted the same as in [Figure 1C](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.011](10.7554/eLife.17978.011)

Lactic acid concentration influences the strength of the \[*GAR*^+^\] activity state {#s2-4}
------------------------------------------------------------------------------------

Since environmental conditions can exert a strong influence on the amount of lactic acid produced by bacteria, we next tested differing amounts of lactic acid, over a larger concentration regime. Even the lowest concentration we tested in this experiment, 0.015%, increased the number of colonies that arose on a GLY + GlcN plate by nearly three orders of magnitude, such that approximately 5% of cells grew into medium-sized colonies ([Figure 5A](#fig5){ref-type="fig"}). Increasing concentrations of lactic acid up to 0.25% did not strongly increase the degree of induction. However, 1% lactic acid caused an even stronger induction, such that nearly all cells in the population grew into large colonies on GLY + GlcN media ([Figure 5A](#fig5){ref-type="fig"}).10.7554/eLife.17978.012Figure 5.The strength of the \[*GAR*^+^\] phenotype depends on the concentration of lactic acid used for induction.(**A**) Plating assay (see Materials and methods) showing that L-lactic acid strongly induced \[*GAR*^+^\] over a wide concentration range. Plotted the same as in [Figure 1C](#fig1){ref-type="fig"}. Ten-fold dilutions were used for plates lacking lactic acid and 10,000-fold dilutions were used for plates containing lactic acid (**B**) Single \[*GAR*^+^\] colonies were picked from two representative concentrations in (A), propagated (restreaked) on non-selective medium (GLY) for approximately 75 generations, and then re-spotted on GLY + GlcN in five-fold serial dilutions. Four biological replicates are shown for each induced group, and two for uninduced cells. Note the growth in the third spots (highest dilution) of 0.0625% L-LA induced cells on GLY + GlcN.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.012](10.7554/eLife.17978.012)

Like virtually all prions, \[*GAR*^+^\] can exist in multiple 'strains' -- different heritable and stable activity states. When they arise spontaneously on selective GLY + GlcN plates, 'strong' \[*GAR*^+^\] colonies are larger than 'weak' \[*GAR*^+^\] colonies ([@bib9]; [@bib29]). Both activity states are heritable over long biological timescales ([@bib9]; [@bib29]). We picked small-sized colonies that had been induced with low concentrations of lactic acid, and large colonies that had been induced with higher concentrations of lactic acid and propagated them for \~75 generations on non-selective rich medium (YPD). We then returned them to GLY + GlcN plates. The small colonies that had originally been induced with low concentrations of lactic acid grew modestly on GLY + GlcN, in a manner that mimicked 'weak' \[*GAR*^+^\] strains ([Figure 5B](#fig5){ref-type="fig"}). The large colonies that had originally been induced with high concentrations of lactic acid grew robustly on GLY + GlcN, in a manner that mimicked 'strong' \[*GAR*^+^\] strains ([Figure 5B](#fig5){ref-type="fig"}). Thus, alterations in the concentration of lactic acid produced by inducing bacteria may engage different heritable activity states, or so-called 'strains', of the \[*GAR*^+^\] prion.

Lactic acid induces \[*GAR*^+^\]-like epigenetic states in evolutionarily distant fungal species {#s2-5}
------------------------------------------------------------------------------------------------

Glucose repression has evolved multiple times in the fungal lineage ([@bib24]). *Dekkera bruxellensis*, an organism used in the production of lambic beers that diverged from *S. cerevisiae* 200 million years ago, uses a distinct mechanism for engaging stringent glucose repression ([@bib45]; [@bib53]). We previously established that despite this evolutionary distance, *D. bruxellensis* can spontaneously acquire a \[*GAR*^+^\]-like state to become a metabolic generalist ([@bib30]). This \[*GAR*^+^\]-like state can also be induced by cross-kingdom chemical communication with bacteria. Although the molecular lexicon of cross-kingdom communication can evolve extraordinarily rapidly, the simplicity and ubiquity of lactic acid led us to investigate whether it might also influence heritable reversal of stringent glucose repression in *D. bruxellensis*.

We exposed naïve *D. bruxellensis* strains to lactic acid, guided by our results from *S. cerevisiae*. Concentrations well within the physiological range of lactic acid produced by bacteria (0.02%) induced robust growth on GLY + GlcN ([Figure 6A](#fig6){ref-type="fig"}). We picked colonies from these selections and propagated them for \~75 generations on non-selective rich medium (YPD). In each case, the trait was heritable: induced colonies maintained the ability to circumvent glucose repression ([Figure 6B](#fig6){ref-type="fig"}).10.7554/eLife.17978.013Figure 6.Induction, maintenance, and chaperone dependence of a lactic acid-induced \[*GAR*^+^\]-like state is conserved in the evolutionary distant yeast *Dekkera bruxellensis*.(**A**) Induction of a \[*GAR*^+^\]-like state in *D. bruxellensis.* \[*gar*^−^\] cells were plated on GLY + GlcN (containing 0.1--0.15% glucosamine) medium with or without 0.02% D-lactic acid. Control cells harbor spontaneous \[*GAR*^+^\]. For each of the treatment images, four biological replicates are shown, in five-fold serial dilutions. (**B**) Maintenance and chaperone dependence of the lactic acid-induced \[*GAR*^+^\]-like state in *D. bruxellensis*. Cells induced in A. were propagated non-selectively for \~75 generations by restreaking on YPD plates, then subsequently retested for maintenance of the prion phenotype on GLY + GlcN (0.1--0.15% glucosamine), with or without the Hsp70 inhibitor myricetin (50 μM). Four biological replicates are shown for each induced group, and two shown for the uninduced and propagated \[*gar^−^*\] cells.**DOI:** [http://dx.doi.org/10.7554/eLife.17978.013](10.7554/eLife.17978.013)

The \[*GAR*^+^\]-like states that arise spontaneously or are induced by bacteria in *D. bruxellensis* depend strongly on the activity of Hsp70 chaperones ([@bib30]). We therefore tested whether the *D. bruxellensis* colonies induced by lactic acid to circumvent glucose repression were sensitive to Hsp70 inhibition. We plated serial dilutions of *D. bruxellensis* cells that had been induced with lactic acid on GLY + GlcN plates and on GLY + GlcN plates containing the Hsp70 inhibitor myricetin ([@bib11]; [@bib33]). We used a concentration of this inhibitor that did not significantly affect growth on GLY alone. This treatment significantly reduced the ability of these induced colonies to circumvent glucose repression ([Figure 6B](#fig6){ref-type="fig"}), just as it does for the \[*GAR*^+^\]-like states that arise spontaneously in this organism ([@bib30]). Thus, across a vast evolutionary distance, bacterial production of lactic acid can engage \[*GAR*^+^\]-like mechanisms to heritably convert neighboring fungi from metabolic specialists to metabolic generalists.

Discussion {#s3}
==========

More than a century ago, Louis Pasteur documented what vintners have long since appreciated: the presence of lactic acid producing bacteria in fermentations can often lead to their failure ([@bib43]). Our observations suggest that the ability of lactic acid to elicit the \[*GAR*^+^\] prion could provide a molecular mechanism for those observations. The \[*GAR*^+^\] prion is found in evolutionarily distant fungal species, and can confer strong selective advantage -- converting metabolic specialists to metabolic generalists in a manner that improves fitness in complex microbial communities ([@bib29], [@bib30]). Our data link the common bacterial metabolite lactic acid, both structurally simple and widespread in nature, to this ancient switch in metabolic strategies.

Recent evidence points to important signaling roles for lactic acid in human cancer cells, in the context of the Warburg effect ([@bib1]; [@bib14]; [@bib19]; [@bib37]). Other studies have linked LAB to benefits for human health and disease prevention, however it remains unclear how much these effects are due to the effects of lactic acid on host cells ([@bib32]; [@bib39]; [@bib48]). In at least some cases, LAB appear to exert their health effects by influencing other microbes, for example, modulating the virulence of *Clostridium difficile* ([@bib36]; [@bib55]).

Many mysteries remain regarding the genetic and biochemical features that lead to the \[*GAR*^+^\] prion; findings have so far been limited to its initial characterization ([@bib9]) and discovery of its regulation by environmental cues ([@bib29]). Our discovery of a connection between passive lactic acid uptake and the ability to induce \[*GAR*^+^\] (via our results with *SOK2*) provides new insight into the initiation of this complex cross-kingdom chemical communication. Further molecular understanding of induction by lactic acid, and its links to the unusual biochemistry that fuels \[*GAR*^+^\], stands as a goal for future studies.

Several lines of evidence suggest that other molecules may modulate \[*GAR*^+^\] induction by lactic acid. Although we were able to fully reconstitute induction with lactic acid alone, the kinetics were slightly faster in conditioned media. Moreover, some of the bacteria that induce \[*GAR*^+^\] in *S. cerevisiae* do not induce the \[*GAR*^+^\]-like state in *D. bruxellensis*, even though high levels of lactic acid can induce the prion in each of these organisms. An intriguing but plausible explanation is that other bacterially secreted factors influence perception of the lactic acid signal, and that the effects of these molecules may also be species specific. Indeed, there is precedent for this behavior in choanoflagellates, where two bacterially secreted lipids were required to recapitulate full induction of rosette, multicellular colony formation ([@bib2]; [@bib54]). Finally, although we have shown that *S. gallinarium* induces \[*GAR*^+^\] via lactic acid, it is entirely possible that other molecules could also fuel this cross-kingdom interaction in diverse ecological niches. There is also precedent in mechanisms of quorum sensing for competition among inducers secreted by different bacteria ([@bib15]; [@bib18]).

Perhaps most remarkably, our study raises the possibility that other prion-like epigenetic states could be regulated by common metabolites, at times in service of cross-species communication. Prior studies have highlighted the fact that general stressors that perturb protein homeostasis can modestly elevate the frequency of cells harboring the \[*PSI*^+^\] or \[*MOT3*^+^\] prions ([@bib27]; [@bib49]). These intrinsic links between stress responses and prion switching ensure that subpopulations of cells can diversify their phenotypes when they are ill-suited to the environment. Our findings extend this biology to a more concerted, switch-like behavior in which prions can serve as a target for rapid and effective cross-species communication.

Biological niches like the human body harbor microbial communities that are far more complex than those we have studied here ([@bib38]). It is striking that the robust connection we have discovered between a simple metabolite and a heritable change in metabolic strategy has been missed despite a multitude studies in this model organism. Our observations thus underscore the potential of cross-kingdom molecular communication to illuminate biological processes, in particular its capacity to elicit heritable, epigenetic transformations of biological traits. Recent progress in metabolomics and metagenomics motivate deeper exploration of such interactions between species, at both the molecular and systems levels.

Materials and methods {#s4}
=====================

Yeast and bacterial media and strain maintenance {#s4-1}
------------------------------------------------

Bacteria strains were cultured on LB agar (Research Products International, Mt. Prospect, IL and BD-Difco, Franklin Lakes, NJ) plates. Yeast strains were cultured on either: (1) YPD agar or liquid (RPI and BD-Difco), (2) YP-Glycerol agar (1% Yeast Extract (BD Bacto), 2% Peptone (BD BBL/Difco), 2% glycerol (Sigma-Aldrich, St. Louis, MO and Amresco, Solon, OH), 2% agar (IBI Scientific, Peosta, IA\]), or (3) "\'GLY + GlcN"\' agar (same mixture as YP-Glycerol) which is supplemented with 0.05% glucosamine hydrochloride (Sigma-Aldrich) (0.1--0.15% for *D. bruxellensis*) that was added from a filter-sterilized 5% stock once media cooled to \~60°C after autoclaving. We noticed that the stringency of selection for \[*GAR*^+^\] cells on GLY + GlcN media was dependent on the source of yeast extract and peptone, and therefore recommend the aforementioned suppliers, as other sources for unknown reasons sometimes imposed much weaker selection. Myricetin (Sigma-Aldrich) was made into a stock solution of 15.7 mM in 100% ethanol, and then diluted to a final concentration of 50 μM in agar medium once cooled to \~60°C after autoclaving.

Strains were maintained using standard microbiological techniques. Bacteria and *S. cerevisiae* strains were grown up in 2--5 mL cultures at 30°C shaking or rotating overnight for most experiments; for experiments requiring smaller volumes they were grown in 200 μL volumes in microtiter plates. All *D. bruxellensis* strains were grown at room temperature until saturation for liquid or sufficiently large colonies for agar plates, typically requiring at least 5 days of growth.

Serial dilutions, starting from saturated cultures, were performed in 96-well plates using multichannel pipettes, and cells were spotted gently onto agar plates using a blot replicating tool (V&P Scientific VP404A, San Diego, CA). For *S. cerevisiae* strains, GLY plates were grown for 2 days before imaging. GLY + GlcN plates were grown 5--7 days before imaging. *D. bruxellensis* strains required several extra days of growth for single colonies to become visible.

Activity guided fractionation {#s4-2}
-----------------------------

Bacterial strains that induced yeast growth on GLY + GlcN media were grown in large scale to purify the active component. Strains were grown from single colonies in 5 mL LB cultures overnight at 30°C and with 250 rpm shaking. The inoculum was then transferred to Erlenmeyer flasks containing 200 mL YP-Glycerol and incubated for 72 hr at 250 rpm, 30°C. The media were centrifuged (30 min at 6000 rpm, Beckman (Brea, CA) JLA 8.1 rotor), and passed through a 0.22 μm filter. The filter-sterilized media was acidified to pH \~1 using 2M HCl, and extracted with a threefold volumetric excess of ethyl acetate. The organic extracts were dried over sodium sulfate, concentrated on a rotary evaporator, suspended in 2--4 mL water, and neutralized with sodium hydroxide. The extract was purified by preparative HPLC using a gradient of acetonitrile (solvent B, Fisher Scientific (Waltham, MA), containing 0.1% formic acid) in milli-Q water (solvent A, containing 0.1% formic acid) on a reversed-phase C18 column (Phenomenex (Torrance, CA) Luna 5U, 100A, 250 × 21.29 mm). The following program was used: 10 mL/min; ramp from 0 to 20 min of 2% to 35% B, followed by a 10 min wash cycle; collect 0.5 min fractions from 7 to 13 min.

Collected fractions were dried in a speed-vac, suspended in water (\~5 mL) and passed through a 0.22 μm filter. Active fractions were identified by assaying their ability to induce growth of YDJ1034 in typically non-permissive GLY + GlcN media containing crude bacterial extracts or HPLC fractions (10 to 25% of total media volume). Fractions that supported yeast growth in GLY + GlcN were combined and subjected to subsequent rounds of semi-preparative HPLC using a gradient of acetonitrile (containing 0.1% formic acid -- solvent B) in water (containing 0.1% formic acid -- solvent A) on a reversed-phase C18 column (Phenomenex Luna 5U, 100A, 250 x 10.00 mm). The following program was used: 2.4 mL/min; ramp from 0 to 20 min of 2% to 10% B, followed by a 15 min wash cycle; collect 0.2 min fractions from 8.4 to 9.4 min. Fractions were analyzed by high-resolution HPLC-MRM-mass spectrometry and NMR spectroscopy. The active fractions contained high levels of lactic acid, which was confirmed by NMR and by co-injection with a purified standard ([Figure 1B](#fig1){ref-type="fig"}).

Prion induction using lactic acid {#s4-3}
---------------------------------

Multiple sources of lactic acid yielded similar results. We tested sodium D-lactate (Sigma-Aldrich 71716), sodium L-lactate (Sigma-Aldrich L7022), D-lactic acid zinc salt (MP Biomedicals, Santa Ana, CA), and L-(+)-lactic acid (Sigma-Aldrich L6402). Excess NaCl was tested in control reactions to mimic the sodium chloride produced during naturalization of sodium lactate and found to produce no phenotypic differences. Lactic acid was added to GLY + GlcN medium at indicated concentrations before autoclaving, and pH was balanced if necessary to ensure it was within \~0.1 units or less of control media lacking lactic acid (pH \~6.8).

For the plating assay, *S. cerevisiae* W303 strains were plated with 100 μL volumes for all plates. For BY4741 strains, 250 μL volumes were plated for GLY + GlcN plates +/-- lactic acid (no cell dilution), while 100 μL was used for GLY plates. Cell dilution was empirically determined to obtain plates containing between approximately 25 and 300 colonies per plate, which were counted using an aCOLyte colony counter (Synbiosis, Cambridge, England). For all GLY plates, a 100,000-fold dilution of saturated culture was plated. For GLY + GlcN plates for W303 strains, a 10-fold dilution of saturated culture was plated; for GLY + GlcN plates containing lactic acid, dilutions of 1000-fold or 10,000-fold were plated to achieve a suitable colony number for W303 strains.

Induction frequency was calculated by normalizing the number of colony forming units (CFUs) on the GLY + GlcN plates to the total possible number on GLY plates after accounting for cell dilutions, reported as \[*GAR*^+^\] cfu/total cfu. We noted some variability in values of \[*GAR*^+^\] cfu/total cfu from experiment to experiment (e.g. for spontaneous rate between [Figure 1C](#fig1){ref-type="fig"} and [Figure 5A](#fig5){ref-type="fig"}), however the qualitative relationship between lactic acid concentration and increased \[*GAR*^+^\] cfu/total cfu was maintained across all dilutions tested. For induction of *D. bruxellensis* strains, cells were spotted in serial dilutions on plates containing lactic acid. Single colonies were picked from the highest dilution and propagated as described in figure legends.

Strain constructions {#s4-4}
--------------------

Diploids were constructed by crossing indicated BY4741 haploids to the BY4742 parental strain (ATCC, Manassas, VA) by mixing a bead of cells of each strain together on a YPD plate and growing overnight. A small globule of this cell mixture was then restreaked to single colonies on SD-Lys-Met agar plates to select for diploids.

Deletion mutants in the W303 background were created by amplifying a *KanMX* construct from corresponding gene deletion mutants from the BY4741 library, using primers listed in [Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}. Approximately 500 ng of purified construct was transformed into YDJ1034, and integrants were selected on agar plates containing G418 (Fisher Scientific). All gene deletions were confirmed by PCR using primers listed in [Supplementary file 1C](#SD1-data){ref-type="supplementary-material"}.

Prion curing and sporulations {#s4-5}
-----------------------------

Curing of the \[*GAR*^+^\] phenotype ([Figure 2B](#fig2){ref-type="fig"}) was achieved by transformation of lactic acid induced cells with PDJ281 (Hygromycin resistant, [Supplementary file 1D](#SD1-data){ref-type="supplementary-material"}), restreaking multiple transformants to single colonies on YPD plates containing 400 ug/mL hygromycin (Gold Biotechnology, Olivette, MO) a total of five times, then restreaking in the same manner on YPD plates twice before confirming each clone had lost the plasmid by testing on YPD+hygromycin. These clones were grown in liquid YPD cultures before testing on GLY + GlcN media.

Spontaneous and lactic acid-induced \[*GAR*^+^\] diploids (W303 background, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) were isolated from single colonies grown on GLY + GlcN or GLY + GlcN + lactic acid plates and grown in Pre-SPO liquid media (YPD with 6% glucose) for 3 days at room temperature. Cells were then pelleted and washed twice in SPO media (1% Potassium Acetate (Sigma-Aldrich), 320 mg CSM-Met powder (Sunrise Science, San Diego, CA), 20 mg Methionine (Sigma-Aldrich) per liter), and then diluted ten-fold to obtain 3 mL cultures in SPO media. These cultures were incubated on a rotary wheel for one week at room temperature, before dissecting tetrads on a Singer Instruments MSM400 (Somerset, UK). Recovered spores were grown to saturation in liquid YPD before testing on GLY + GlcN media.

Data collection and display {#s4-6}
---------------------------

Yeast plates were imaged using an Epson Perfection V700 Photo Scanner (Long Beach, CA). Plots were made using PRISM 6 software (GraphPad, La Jolla, CA).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A common bacterial metabolite elicits prion-based bypass of glucose repression\" for consideration by *eLife*. Your article has been favorably evaluated by Jessica Tyler (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This succinct paper reports the solution to a mystery posed by the authors\' earlier work on induction of the \[*GAR*^+^\] \'prion\' by a low molecular weight molecule. That the inducer is lactic acid makes sense given the known ability of lactic acid-producing bacteria to induce \[*GAR*^+^\] as well as the historical context vis-à-vis Pasteur\'s observations. The data that demonstrate that lactic acid is a \[*GAR*^+^\] inducer are well controlled and nicely presented although the \'induction vs. selection\' argument that is always raised in such studies should ideally have been explicitly addressed in the experimental design and resulting Discussion. The manuscript is clearly written and experimental design is straightforward.

However, several issues need to be addressed before this manuscript can be accepted for publication.

Essential revisions:

1\) Authors need to show that the glucosamine resistant colonies induced by lactic acid indeed contain a \[*GAR*^+^\] prion. The evidence provided in the manuscript includes a dominance in genetic crosses and inhibition by myricetin, an inhibitor of Hsp70. However, this is insufficient to conclude that the observed phenotype is controlled by a prion. First, authors need to show that in the lactic acid induced colonies, this phenotype shows non-Mendelian inheritance in meioisis and/or is transmitted by cytoplasmic infection (cytoduction).

2\) Second, they need to show that myrecitin irreversibly cures \[*GAR*^+^\] rather than inhibiting it. it isn\'t clear from the paper if the phenotypic inhibition by inhibition of HSP70 is due to \"curing\" some cells of the prion, or a general inhibition of phenotype in all cells. Also it isn\'t clear if this \"prion\" inhibition is present only during HSP70 inhibition or if transient inhibition of HSP70 has a lasting effect on the so called \[*GAR*^+^\] phenotype.

3\) Third, at least in some isolates obtained from induction by lactic acid, either genetic or biochemical characterization needs to be performed showing that the phenotype under investigation is indeed related to proteins implicated in originally described \[*GAR*^+^\]. For example, two proteins have been identified as being associated with \[*GAR*^+^\], one (Pma1 p) is a major plasma membrane proton pump while the other (Std1p) is a transcription factor that among other targets, regulates hexose transporters. Does lactic acid influence the levels/activity of either of these in any plausible way? (In case if non-Mendelian inheritance/cytoduction and chaperone sensitivity are proven, but clear identification of the obtained isolates as \[*GAR*^+^\] is not done, results might still be publishable, but authors should be more careful in interpretations and should talk about the non-Mendelian prion-like elements similar to previously described \[*GAR*^+^\], rather than about \[*GAR*^+^\] prion per se.

4\) The same comments apply to \[*GAR*^+^\] isolates obtained in Dekkera yeast. As detailed characterization of such isolates in Dekkera is more difficult than in Saccharomyces, authors should probably change wording and refer to them more accurately, e. g. as glucosamine resistant colonies similar to \[*GAR*^+^\].

5\) Authors talk about mitotic stabilities of \[*GAR*^+^\] isolates, but don\'t show actual data. These data need to be shown.

6\) A further complexity alluded to by the authors in their brief Discussion is the possibility that there are other molecular \'co-factors\' that are part of the induction mechanism -- although clearly lactic acid can induce \[*GAR*^+^\] without added (but unidentified) \'co-factors\'.

7\) What is disappointing is that the authors do not really attempt to come up with a plausible model based on their data and what was previously published about \[*GAR*^+^\] and its induction. The very nature of the \[*GAR*^+^\] determinant itself remains a mystery; it certainly shows some of the key genetic properties of the other well established yeast prions, yet there are also distinct differences such as a lack of reliance on Hsp104-mediated disaggregation for propagation and the lack of an association with a specific amyloid-forming protein. The authors also mention that \[*GAR*^+^\] is semi-dominant in \[*GAR*^+^\] x \[*gar*^-^\] crosses; do other prions show this behaviour?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"A common bacterial metabolite elicits prion-based bypass of glucose repression\" for further consideration at *eLife*. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) The last sentence of the Abstract sounds too strong, as the paper by Holmes et al. 2013 has claimed that the \[*MOT3+*\] prion can be induced by ethanol. Even though an argument of induction versus selection could possibly be made there (especially as \[*MOT3+*\] increases ethanol resistance), such a statement requires an elaboration and is more appropriate for the Discussion rather than Abstract. Possibly a substitution of \"small molecule\" with a \"normal bacterial metabolite\" (or \"a small molecule produced by bacteria\") would suffice.

2\) This would be helpful to include the growth curves in the presence of lactic acid, shown in Response to reviewers, into a supplement.
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Author response

*Summary:*

*This succinct paper reports the solution to a mystery posed by the authors\' earlier work on induction of the \[GAR^+^\] \'prion\' by a low molecular weight molecule. That the inducer is lactic acid makes sense given the known ability of lactic acid-producing bacteria to induce \[GAR^+^\] as well as the historical context vis-à-vis Pasteur\'s observations. The data that demonstrate that lactic acid is a \[GAR^+^\] inducer are well controlled and nicely presented although the \'induction vs. selection\' argument that is always raised in such studies should ideally have been explicitly addressed in the experimental design and resulting Discussion.* To address the induction vs. selection argument, we have examined whether \[*GAR*^+^\] cells have accelerated growth rates compared to \[*gar*^--^\] cells in the presence of inducing concentrations of lactic acid, which might raise the possibility that we could be favoring selection for \[*GAR*^+^\] colonies in our assays to measure induction frequency.

We grew four biological replicates of \[*GAR*^+^\] or \[*gar*^--^\] cells in YP-glycerol or YP-glycerol + 0.35% D-lactic acid liquid media, measuring OD600 every 6 minutes over 4 days using an automated microplate reader. As shown in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, \[*GAR*^+^\] cells neither grew better than \[*gar*^--^\] cells in glycerol alone nor when lactic acid was added to the medium. While we cannot exclude the possibility that a \[*gar*^--^\] cell switching to a \[*GAR*^+^\] state may introduce some immediate but short-lived growth advantage in lactic acid, we posit that this difference would need to be almost inconceivably large to result in the even the lowest levels of induction that we measured.

*The manuscript is clearly written and experimental design is straightforward.*

*However, several issues need to be addressed before this manuscript can be accepted for publication.*

*Essential revisions:*

*1) Authors need to show that the glucosamine resistant colonies induced by lactic acid indeed contain a \[GAR^+^\] prion. The evidence provided in the manuscript includes a dominance in genetic crosses and inhibition by myricetin, an inhibitor of Hsp70. However, this is insufficient to conclude that the observed phenotype is controlled by a prion. First, authors need to show that in the lactic acid induced colonies, this phenotype shows non-Mendelian inheritance in meioisis and/or is transmitted by cytoplasmic infection (cytoduction).*

We thank the reviewer for this suggestion -- it is a critical point. We have now added data showing non-Mendelian inheritance of the induced phenotype in meiosis. These data appear in a supplemental figure associated with [Figure 2](#fig2){ref-type="fig"} ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

*2) Second, they need to show that myrecitin irreversibly cures \[GAR^+^\] rather than inhibiting it. it isn\'t clear from the paper if the phenotypic inhibition by inhibition of HSP70 is due to \"curing\" some cells of the prion, or a general inhibition of phenotype in all cells. Also it isn\'t clear if this \"prion\" inhibition is present only during HSP70 inhibition or if transient inhibition of HSP70 has a lasting effect on the so called \[GAR^+^\] phenotype.*

We agree that it is important to test whether transient perturbations in Hsp70 function are sufficient to permanently eliminate the induced \[*GAR*^+^\] phenotype. To rigorously address this question we have employed a dominant negative Hsp70 variant (Ssa1-K69M) in this revision. We transiently inhibited Hsp70 activity by expressing this dominant negative variant of Hsp70 from a plasmid and then 'cured' the cells of this construct, restoring normal Hsp70 function. Just as it did with spontaneous and bacterially-induced \[*GAR*^+^\] (Jarosz et al., 2014a), this regimen eliminated the \[*GAR*^+^\] phenotype induced by lactic acid. These data are now provided in [Figure 2B](#fig2){ref-type="fig"}.

We have moved the myricetin data from *S. cerevisiae* to [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, in part to motivate the use of this method for *D. bruxellensis \[GAR*^+^\]-like cells described in [Figure 6B](#fig6){ref-type="fig"}. (*D. bruxellensis* is not genetically tractable.) Accordingly, we have altered the language we use to describe the \[*GAR*^+^\]-like state in this organism.

*3) Third, at least in some isolates obtained from induction by lactic acid, either genetic or biochemical characterization needs to be performed showing that the phenotype under investigation is indeed related to proteins implicated in originally described \[GAR^+^\]. For example, two proteins have been identified as being associated with \[GAR^+^\], one (Pma1 p) is a major plasma membrane proton pump while the other (Std1p) is a transcription factor that among other targets, regulates hexose transporters. Does lactic acid influence the levels/activity of either of these in any plausible way? (In case if non-Mendelian inheritance/cytoduction and chaperone sensitivity are proven, but clear identification of the obtained isolates as \[GAR^+^\] is not done, results might still be publishable, but authors should be more careful in interpretations and should talk about the non-Mendelian prion-like elements similar to previously described \[GAR^+^\], rather than about \[GAR^+^\] prion per se.*

Spontaneous \[*GAR*^+^\] arises from alterations in the structure of Pma1 that influence its association with Std1. We have added data to address the requirement for Pma1 in lactic acid's capacity to induce the \[*GAR*^+^\] state, now in [Figure 2C](#fig2){ref-type="fig"}. *PMA1* is an essential gene, so we took advantage of a strain containing a degron allele that reduces its mRNA levels significantly (Breslow et al., 2008). We show that this strain produces colonies on GLY + GlcN plates at a low frequency that is not further induced by lactic acid. Thus we conclude that the ability of lactic acid to induce the \[*GAR*^+^\] state depends on the level of Pma1 in the cell, just as spontaneous prion acquisition does.

*4) The same comments apply to \[GAR^+^\] isolates obtained in Dekkera yeast. As detailed characterization of such isolates in Dekkera is more difficult than in Saccharomyces, authors should probably change wording and refer to them more accurately, e. g. as glucosamine resistant colonies similar to \[GAR^+^\].*

We have altered the language accordingly when referring to the "\[*GAR*^+^\]-like" state in *Dekkera*.

*5) Authors talk about mitotic stabilities of \[GAR^+^\] isolates, but don\'t show actual data. These data need to be shown.*

Thanks for noticing our wording error. We have edited this section to reflect the intention of our experiments.

*6) A further complexity alluded to by the authors in their brief Discussion is the possibility that there are other molecular \'co-factors\' that are part of the induction mechanism -- although clearly lactic acid can induce \[GAR^+^\] without added (but unidentified) \'co-factors\'.*

We have expanded on this point in the Discussion.

*7) What is disappointing is that the authors do not really attempt to come up with a plausible model based on their data and what was previously published about \[GAR^+^\] and its induction. The very nature of the \[GAR^+^\] determinant itself remains a mystery; it certainly shows some of the key genetic properties of the other well established yeast prions, yet there are also distinct differences such as a lack of reliance on Hsp104-mediated disaggregation for propagation and the lack of an association with a specific amyloid-forming protein. The authors also mention that \[GAR^+^\] is semi-dominant in \[GAR^+^\] x \[gar^-^\] crosses; do other prions show this behaviour?*

We agree there are many mysteries that remain to be uncovered for the \[*GAR*^+^\] prion. Moreover, surprisingly little is known about how yeast cells respond to lactic acid compared to other carbon sources. This lack of knowledge in both areas hampers our ability to propose a mechanistic model that is more than just conjecture. We now allude to this in the Discussion, highlighting our result that *SOK2* provides a link between the two responses.

The similarities and differences in biochemical properties of \[*GAR*^+^\] compared to other prions is indeed interesting. Semi-dominance is key among them. This work raises another interesting point of comparison that fascinates us -- can other prions be induced by common environmental factors? Of course, we would not expect that lactic acid could induce all yeast prions, but discovery of inducers for other prions could substantially revise our understanding of the ecological dynamics at play in prion biology. We also now incorporate these lines of thinking in the Discussion.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*Thank you for resubmitting your work entitled \"A common bacterial metabolite elicits prion-based bypass of glucose repression\" for further consideration at eLife. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:*

*1) The last sentence of the Abstract sounds too strong, as the paper by Holmes et al. 2013 has claimed that the \[MOT3+\] prion can be induced by ethanol. Even though an argument of induction versus selection could possibly be made there (especially as \[MOT3+\] increases ethanol resistance), such a statement requires an elaboration and is more appropriate for the Discussion rather than Abstract. Possibly a substitution of \"small molecule\" with a \"normal bacterial metabolite\" (or \"a small molecule produced by bacteria\") would suffice.*

We have adjusted the language in the Abstract to reflect this useful point. We have also altered the Discussion slightly to reflect the nuance raised here by the reviewers. Holmes et al. provide as evidence favoring induction that exposure to 12% ethanol "was not overtly toxic to cells, indicating that ethanol did not merely select for pre-existing \[*MOT3*^+^\] cells," but they establish that these effects are derived from general perturbations in protein homeostasis. This is consistent with prior work by Tyedmers et al., which found that multiple general proteostasis stressors could induce another prion, \[*PSI*^+^\]. We now make these points explicitly in the Discussion.

*2) This would be helpful to include the growth curves in the presence of lactic acid, shown in Response to reviewers, into a supplement.*

Thank you for the suggestion. We uploaded this data as [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, added the figure legend, and tracked changes in the main text to reflect its inclusion.

[^1]: These authors contributed equally to this work.
